4.4 Article

Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Peripheral Vascular Disease

Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization

Sarah R. Pickens et al.

ANGIOGENESIS (2011)

Article Pathology

Endothelial Fli1 Deficiency Impairs Vascular Homeostasis A Role in Scleroderma Vasculopathy

Yoshihide Asano et al.

AMERICAN JOURNAL OF PATHOLOGY (2010)

Review Cell Biology

Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis

Mirko Manetti et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)

Review Dermatology

Future treatments in systemic sclerosis

Yoshihide Asano

JOURNAL OF DERMATOLOGY (2010)

Article Multidisciplinary Sciences

Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?

Jo N. Fleming et al.

PLOS ONE (2008)

Article Gastroenterology & Hepatology

Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis

JH Kwon et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)

Article Rheumatology

Elevated matrix metalloproteinase-9 in patients with systemic sclerosis

WU Kim et al.

ARTHRITIS RESEARCH & THERAPY (2005)